Dongwha Pharm-MSD Korea signs license agreement of antidepressant ‘Remeron’

Published: 2017-09-14 16:27:00
Updated: 2017-09-14 15:51:14

Dongwha Pharm(CEO Ji-Hoon Sohn) signed a MSD’s exclusive sale and supply agreement of Remeron(generic name: mirtazapine), a MSD’s antidepressant, in Korea on the 8th of September.

Remeron, a MSD’s NaSSA(antidepressant with the Noradrenergic and Specific Serotonergic Antidepressants) mechanism, w...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.